In the pan-cancer analysis performed by Thorsson and colleagues, C3 had a significantly better outcome than that of C4; however, the steroid phenotype provides more characteristics regarding tumor aggressiveness and outcome prognosis in ACC than that of the C3-C4 signatures. The gene discussed is C4A; the disease is neoplasm.